查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1462911

间质干细胞市场，按产品类型、应用、最终用途、国家和地区 - 2024-2032 年行业分析、市场规模、市场份额和预测

Mesenchymal Stem Cells Market, By Product Type, By Application, By End-Use, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 310 Pages | 商品交期: 2-3个工作天内

价格

报告要点

2023 年间质干细胞市场规模为 34.54 亿美元，2024 年至 2032 年复合CAGR为 11.5%。

间质干细胞市场-市场动态

再生医学偏好拉动市场需求

间质干细胞已成为再生医学领域非常有用的工具。它们可以从许多组织中提取，例如牙髓、脂肪组织、骨髓和脐带。由于间质干细胞具有分化成多种组织类型的能力及其免疫调节特性，因此越来越多地使用间质干细胞来修復受损或退化的组织，从而极大地支持了市场。鑑于对组织损伤和慢性疾病的有效疗法的需求不断增长，再生医学市场预计在不久的将来将会扩大。此外，MSC 的广泛使用有助于骨折、软骨畸形、韧带损伤和肌腱损伤的癒合，对该行业产生了积极影响。透过将间质干细胞直接注射到受伤部位，可以促进组织再生并减少炎症，从而改善效果并加速癒合过程。随着人口老化和肌肉骨骼疾病盛行率的上升，预计基于间质干细胞的疗法将在骨科领域越来越受欢迎。

间质干细胞市场 - 关键见解

根据我们的研究分析师分享的分析，预计全球市场在预测期内（2024-2032 年）每年将以 11.5% 左右的CAGR成长

根据产品类型细分，骨髓细分市场预计将在预测期内主导市场

根据应用细分，治疗领域预计将在预测期内引领市场成长

按地区划分，北美是 2023 年的主要收入来源

间质干细胞市场-細項分析：

全球间质干细胞市场根据产品类型、应用、最终用途和地区进行细分。

根据产品类型，市场分为脂肪组织、骨髓、脐带和其他。预计骨髓细分市场将在预测期内主导市场。骨髓间质干细胞一直是许多研究的主题，并被认为是该领域最好的。这些细胞具有分化成多种细胞类型的能力，包括脂肪细胞、软骨细胞和成骨细胞。这项特性使其能够用于广泛的治疗应用，例如发炎和免疫疾病以及骨科和肌肉骨骼疾病的治疗。此外，间质干细胞可以经常从骨髓中获得，这使其成为科学家和医疗从业者的热门选择。

根据应用，市场分为研究、治疗和其他。预计治疗领域将在预测期内引领市场成长。间质干细胞在治疗一系列疾病和创伤方面显示出良好的效果，例如烧伤、自体免疫疾病、心臟和神经系统问题、骨骼和软骨异常以及自体免疫疾病。随着越来越多的临床试验和学术研究证明间质干细胞的安全性和有效性，间质干细胞在再生医学的应用越来越多。此外，预计糖尿病和癌症等慢性疾病发病率的上升将增加对基于 MSC 的疗法的需求。

根据最终用途，该行业分为肌肉骨骼、骨科、肿瘤、心血管和其他。

间质干细胞市场 - 地理洞察

从地理来看，该市场广泛分布于北美、拉丁美洲、欧洲、亚太、中东和非洲等地区。这些区域根据开展业务的国家进一步划分。预计北美在预测期内将占据大部分市场份额。在美国，正在进行大量临床试验，以评估间质干细胞作为一系列严重疾病的潜在治疗方法的安全性和有效性。此外，北美拥有相当一部分参与间质干细胞供应和商业化的最大公司。此外，对新疗法的需求不断增长，鼓励性的政府政策以及产业参与者加强努力创造复杂的间质干细胞疗法来治疗慢性疾病。这些因素对该地区的商业霸主地位发挥了作用。

间质干细胞市场-竞争格局：

市场的主要参与者包括武田药品工业株式会社、默克公司、赛默飞世尔科技公司、Lonza Group Ltd、Stemcell Technologies, Inc.、Cellular Dynamics International, Inc.、Regeneus Ltd、Tissue Genesis, Inc. 、Cesca Therapeutics Inc.和伊普森。这些参与者采取了各种策略，如产品推出、扩张、投资、合作等，以获得最大的市场份额。

最近的发展：

2023 年 5 月，透过与 Histocell 合作，REPROCELL 将提供 CDMO 服务，生产由间质干细胞 (MSC) 製成的先进疗法药物产品 (ATMP)。 REPROCELL 的分包合作伙伴 Histocell 经授权在西班牙毕尔巴鄂开设了 GMP ATMP 生产工厂。自2008年以来，Histocell一直提供GMP製造服务。该公司在生产治疗性 MSC 产品方面拥有丰富的经验，例如外泌体细胞治疗和无细胞 MSC 衍生的分泌组。

目录

第一章：间质干细胞市场概述

  • 研究范围
  • 市场预估年份

第 2 章：执行摘要

  • 市场片段
    • 按产品类型分類的间质干细胞市场片段
    • 间质干细胞市场片段（依应用）
    • 依最终用途分類的间质干细胞市场片段
    • 按国家/地区分類的间质干细胞市场片段
    • 按地区分類的间质干细胞市场片段
  • 竞争洞察

第 3 章：间质干细胞主要市场趋势

  • 间质干细胞市场驱动因素
    • 市场驱动因素的影响分析
  • 间质干细胞市场限制
    • 市场限制影响分析
  • 间质干细胞市场机会
  • 间质干细胞市场未来趋势

第 4 章：间质干细胞产业研究

  • PEST分析
  • 波特五力分析
  • 成长前景图
  • 规范架构分析

第 5 章：间质干细胞市场：COVID-19 影响分析

  • COVID-19 之前的影响分析
  • COVID-19 后影响分析
    • 表现最佳的市场区隔
    • 边际增长部分
    • 最鬆散的部分
    • 边际损失部分

第 6 章：间质干细胞市场格局

  • 2023 年间质干细胞市占率分析
  • 按主要製造商分類的故障数据
    • 既定玩家分析
    • 新兴玩家分析

第 7 章：间质干细胞市场 - 依产品类型

  • 概述
    • 按产品类型分類的细分市场占有率分析
    • 脂肪组织
    • 骨髓
    • 脐带
    • 其他的

第 8 章：间质干细胞市场 - 按应用

  • 概述
    • 按应用分類的细分市场占有率分析
    • 研究
    • 治疗性
    • 其他的

第 9 章：间质干细胞市场 - 依最终用途

  • 概述
    • 按最终用途分類的细分市场份额分析
    • 医院
    • 肌肉骨骼
    • 骨科
    • 肿瘤学
    • 心血管
    • 其他的

第 10 章：间质干细胞市场 - 依地理位置

  • 介绍
    • 按地理位置分類的细分市场占有率分析
  • 北美洲
    • 概述
    • 北美间质干细胞主要製造商
    • 北美市场规模和预测（按国家）
    • 北美市场规模和预测（按产品类型）
    • 北美市场规模和预测（按应用）
    • 北美市场规模和预测（按最终用途）
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲间质干细胞主要製造商
    • 欧洲市场规模和预测（按国家）
    • 欧洲市场规模和预测（按产品类型）
    • 欧洲市场规模和预测（按应用）
    • 欧洲市场规模和预测（按最终用途）
    • 德国
    • 义大利
    • 英国
    • 法国
    • 俄罗斯
    • 荷兰
    • 瑞典
    • 波兰
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 概述
    • 亚太地区间质干细胞主要製造商
    • 亚太地区市场规模与预测（按国家）
    • 亚太地区市场规模与预测（依产品类型）
    • 亚太地区市场规模与预测（按应用）
    • 亚太地区市场规模和预测（按最终用途）
    • 印度
    • 中国
    • 日本
    • 韩国
    • 澳洲
    • 泰国
    • 印尼
    • 菲律宾
    • 亚太地区其他地区
  • 拉丁美洲
    • 概述
    • 拉丁美洲间质干细胞主要製造商
    • 拉丁美洲市场规模与预测（按国家）
    • 拉丁美洲市场规模与预测（按产品类型）
    • 拉丁美洲市场规模与预测（按应用）
    • 拉丁美洲市场规模和预测（按最终用途）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲
    • 概述
    • 中东和非洲间质干细胞主要製造商
    • 中东和非洲市场规模及预测（按国家）
    • 中东和非洲市场规模及预测（按产品类型）
    • 中东和非洲市场规模及预测（按应用）
    • 中东和非洲市场规模和预测（按最终用途）
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • MEA 的其余部分

第 11 章：主要供应商分析 - 间质干细胞产业

  • 竞争仪表板
  • 公司简介
    • Takeda Pharmaceutical Company Limited
    • Merck KGaA
    • Thermo Fisher Scientific, Inc.
    • Lonza Group Ltd
    • Stemcell Technologies, Inc.
    • Cellular Dynamics International, Inc.
    • Regeneus Ltd
    • Tissue Genesis, Inc.
    • Cesca Therapeutics Inc
    • Ipsen

第 12 章：360 度分析师视角

第 13 章：附录

  • 研究最终用途学
  • 参考
  • 缩写
  • 免责声明
  • 联络我们
Product Code: ANV2369

REPORT HIGHLIGHT

Mesenchymal Stem Cells Market size was valued at USD 3,454 Million in 2023, expanding at a CAGR of 11.5% from 2024 to 2032.

Within the field of regenerative medicine, adult stem cells known as mesenchymal stem cells (MSCs) exhibit great potential. Bone marrow, adipose tissue (fat), umbilical cord blood, and dental pulp are among the tissues in the body that contain them. Osteoblasts, chondrocytes, myocytes, fat cells, and muscle cells are just a few of the cell types that can be created from MSCs because to their amazing capacity to differentiate.

Mesenchymal Stem Cells Market- Market Dynamics

Preference for regenerative medicine to propel market demand

MSCs have become a very useful tool in the field of regenerative medicine. They can be extracted from a number of tissues, such as tooth pulp, adipose tissue, bone marrow, and umbilical cord. The market is being substantially supported by the increasing use of MSCs for the repair of damaged or degenerated tissues because of their capacity to differentiate into a variety of tissue types and their immunomodulatory qualities. Given the rising need for efficient therapies for tissue damage and chronic illnesses, the market for regenerative medicine is expected to expand in the near future. Furthermore, the industry is being positively impacted by the widespread use of MSCs to aid in the healing of fractures, cartilage deformities, ligament injuries, and tendon injury. It is feasible to promote tissue regeneration and decrease inflammation by injecting MSCs directly into the injured area, improving results and hastening the healing process. MSC-based therapies are predicted to become increasingly popular in orthopedics as the aging population and the prevalence of musculoskeletal disorders rise.

Mesenchymal Stem Cells Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 11.5% over the forecast period (2024-2032)

Based on product type segmentation, the Bone Marrow segment is expected to dominate the market over the forecast period

Based on the application segmentation, the Therapeutic segment is expected to lead the market growth during the forecast period

Based on region, North America was the leading revenue generator in 2023

Mesenchymal Stem Cells Market- Segmentation Analysis:

The Global Mesenchymal Stem Cells Market is segmented based on Product Type, Application, End-Use, and Region.

Based on the product type, the market is categorized into Adipose Tissue, Bone Marrow, Umbilical Cord and Others. The Bone Marrow segment is expected to dominate the market over the forecast period. Bone marrow-derived mesenchymal stem cells have been the subject of much study and are considered the best in their area. These cells have the ability to differentiate into a variety of cell types, including adipocytes, chondrocytes, and osteoblasts. This characteristic enables its use in a wide range of therapeutic applications, such as the management of inflammatory and immunological diseases as well as orthopedic and musculoskeletal conditions. Moreover, mesenchymal stem cells may be obtained from bone marrow quite frequently, which makes it a popular choice for scientists and medical practitioners.

Based on the application, the market is divided into Research, Therapeutic and Others. The Therapeutic segment is expected to lead the market growth during the forecast period. MSCs have shown promising results in the treatment of a range of ailments and traumas, such as burns, autoimmune disorders, heart and neurological issues, anomalies of the bone and cartilage, and autoimmune diseases. MSCs are being used more and more in regenerative medicine as more clinical trials and scholarly research demonstrate their safety and efficacy. Furthermore, it is anticipated that the rising incidence of chronic illnesses like diabetes and cancer would increase demand for MSC-based therapies.

Based on the end-use, the industry is divided into Musculoskeletal, Orthopedics, Oncology, Cardiovascular and Others.

Mesenchymal Stem Cells Market- Geographical Insights

Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business. North America is expected to hold the majority of market share during the forecast period. In the United States, a significant number of clinical trials are being conducted to evaluate the safety and effectiveness of mesenchymal stem cells as a potential treatment for a range of serious illnesses. Moreover, North America is home to a sizable portion of the largest corporations involved in the supply and commercialization of MSCs. Furthermore, there is a growing need for novel treatments, encouraging government policies, and heightened endeavors by industry players to create sophisticated mesenchymal stem cell treatments for the treatment of chronic diseases. These elements have played a part in the region's commercial supremacy.

Mesenchymal Stem Cells Market- Competitive Landscape:

The key players in the market are Takeda Pharmaceutical Company Limited, Merck KGaA, Thermo Fisher Scientific, Inc., Lonza Group Ltd, Stemcell Technologies, Inc. Cellular Dynamics International, Inc. Regeneus Ltd, Tissue Genesis, Inc., Cesca Therapeutics Inc and Ipsen. These players adopted various strategies such as product launch, expansion, investment, collaboration, and others to obtain the maximum market share of the market.

Recent Developments:

In May 2023, through a collaboration with Histocell, REPROCELL will now provide CDMO services to produce Advanced Therapies Medicinal Products (ATMPs) made from mesenchymal stem cells (MSC). Histocell, a subcontracting partner of REPROCELL, has opened a GMP ATMP production plant in Bilbao, Spain, with authorization. Since2008, Histocell has been offering GMP manufacturing services. The company has extensive experience producing therapeutic MSC products, such as exosome cell treatments and cell-free MSC-derived secretome.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL MESENCHYMAL STEM CELLS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Takeda Pharmaceutical Company Limited

Merck KGaA

Thermo Fisher Scientific, Inc.

Lonza Group Ltd

Stemcell Technologies, Inc.

Cellular Dynamics International, Inc.

Regeneus Ltd

Tissue Genesis, Inc.

Cesca Therapeutics Inc

Ipsen

GLOBAL MESENCHYMAL STEM CELLS MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032

  • Adipose Tissue
  • Bone Marrow
  • Umbilical Cord
  • Others

GLOBAL MESENCHYMAL STEM CELLS MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Research
  • Therapeutic
  • Others

GLOBAL MESENCHYMAL STEM CELLS MARKET, BY END-USE- MARKET ANALYSIS, 2019 - 2032

  • Musculoskeletal
  • Orthopedics
  • Oncology
  • Cardiovascular
  • Others

GLOBAL MESENCHYMAL STEM CELLS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1.Mesenchymal Stem Cells Market Overview

  • 1.1.Study Scope
  • 1.2.Market Estimation Years

2.Executive Summary

  • 2.1.Market Snippet
    • 2.1.1.Mesenchymal Stem Cells Market Snippet by Product Type
    • 2.1.2.Mesenchymal Stem Cells Market Snippet by Application
    • 2.1.3.Mesenchymal Stem Cells Market Snippet by End-Use
    • 2.1.4.Mesenchymal Stem Cells Market Snippet by Country
    • 2.1.5.Mesenchymal Stem Cells Market Snippet by Region
  • 2.2.Competitive Insights

3.Mesenchymal Stem Cells Key Market Trends

  • 3.1.Mesenchymal Stem Cells Market Drivers
    • 3.1.1.Impact Analysis of Market Drivers
  • 3.2.Mesenchymal Stem Cells Market Restraints
    • 3.2.1.Impact Analysis of Market Restraints
  • 3.3.Mesenchymal Stem Cells Market Opportunities
  • 3.4.Mesenchymal Stem Cells Market Future Trends

4.Mesenchymal Stem Cells Industry Study

  • 4.1.PEST Analysis
  • 4.2.Porter's Five Forces Analysis
  • 4.3.Growth Prospect Mapping
  • 4.4.Regulatory Framework Analysis

5.Mesenchymal Stem Cells Market: COVID-19 Impact Analysis

  • 5.1.Pre-COVID-19 Impact Analysis
  • 5.2.Post-COVID-19 Impact Analysis
    • 5.2.1.Top Performing Segments
    • 5.2.2.Marginal Growth Segments
    • 5.2.3.Top Looser Segments
    • 5.2.4.Marginal Loss Segments

6.Mesenchymal Stem Cells Market Landscape

  • 6.1.Mesenchymal Stem Cells Market Share Analysis, 2023
  • 6.2.Breakdown Data, by Key Manufacturer
    • 6.2.1.Established Players' Analysis
    • 6.2.2.Emerging Players' Analysis

7.Mesenchymal Stem Cells Market - By Product Type

  • 7.1.Overview
    • 7.1.1.Segment Share Analysis, By Product Type, 2023 & 2032 (%)
    • 7.1.2.Adipose Tissue
    • 7.1.3.Bone Marrow
    • 7.1.4.Umbilical Cord
    • 7.1.5.Others

8.Mesenchymal Stem Cells Market - By Application

  • 8.1.Overview
    • 8.1.1.Segment Share Analysis, By Application, 2023 & 2032 (%)
    • 8.1.2.Research
    • 8.1.3.Therapeutic
    • 8.1.4.Others

9.Mesenchymal Stem Cells Market - By End-Use

  • 9.1.Overview
    • 9.1.1.Segment Share Analysis, By End-Use, 2023 & 2032 (%)
    • 9.1.2.Hospitals
    • 9.1.3.Musculoskeletal
    • 9.1.4.Orthopedics
    • 9.1.5.Oncology
    • 9.1.6.Cardiovascular
    • 9.1.7.Others

10.Mesenchymal Stem Cells Market- By Geography

  • 10.1.Introduction
    • 10.1.1.Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 10.2.North America
    • 10.2.1.Overview
    • 10.2.2.Mesenchymal Stem Cells Key Manufacturers in North America
    • 10.2.3.North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4.North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.2.5.North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.2.6.North America Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.2.7.U.S.
      • 10.2.7.1.Overview
      • 10.2.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3.U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.2.7.4.U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.7.5.U.S. Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.2.8.Canada
      • 10.2.8.1.Overview
      • 10.2.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3.Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.2.8.4.Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.8.5.Canada Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
  • 10.3.Europe
    • 10.3.1.Overview
    • 10.3.2.Mesenchymal Stem Cells Key Manufacturers in Europe
    • 10.3.3.Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4.Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.3.5.Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.6.Europe Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.3.7.Germany
      • 10.3.7.1.Overview
      • 10.3.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3.Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.7.4.Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.7.5.Germany Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.3.8.Italy
      • 10.3.8.1.Overview
      • 10.3.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3.Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.8.4.Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.8.5.Italy Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.3.9.United Kingdom
      • 10.3.9.1.Overview
      • 10.3.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3.United Kingdom Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.9.4.United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.9.5.United Kingdom Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.3.10.France
      • 10.3.10.1.Overview
      • 10.3.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3.France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.10.4.France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.10.5.France Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.3.11.Russia
      • 10.3.11.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.2.Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.11.3.Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.11.4.Russia Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.3.12.Netherlands
      • 10.3.12.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2.Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.12.3.Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.12.4.Netherlands Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.3.13.Sweden
      • 10.3.13.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2.Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.13.3.Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.13.4.Sweden Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.3.14.Poland
      • 10.3.14.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2.Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.14.3.Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.14.4.Poland Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.3.15.Rest of Europe
      • 10.3.15.1.Overview
      • 10.3.15.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3.Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.15.4.Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.15.5.Rest of the Europe Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
  • 10.4.Asia Pacific (APAC)
    • 10.4.1.Overview
    • 10.4.2.Mesenchymal Stem Cells Key Manufacturers in Asia Pacific
    • 10.4.3.Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4.Asia Pacific Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.4.5.Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.6.Asia Pacific Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.4.7.India
      • 10.4.7.1.Overview
      • 10.4.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3.India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.7.4.India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.7.5.India Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.4.8.China
      • 10.4.8.1.Overview
      • 10.4.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3.China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.8.4.China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.8.5.China Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.4.9.Japan
      • 10.4.9.1.Overview
      • 10.4.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3.Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.9.4.Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.9.5.Japan Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.4.10.South Korea
      • 10.4.10.1.Overview
      • 10.4.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3.South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.10.4.South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.10.5.South Korea Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.4.11.Australia
      • 10.4.11.1.Overview
      • 10.4.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3.Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.11.4.Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.11.5.Australia Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.4.12.Thailand
      • 10.4.12.1.Overview
      • 10.4.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3.Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.12.4.Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.12.5.Thailand Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.4.13.Indonesia
      • 10.4.13.1.Overview
      • 10.4.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3.Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.13.4.Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.13.5.Indonesia Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.4.14.Philippines
      • 10.4.14.1.Overview
      • 10.4.14.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3.Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.14.4.Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.14.5.Philippines Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.4.15.Rest of APAC
      • 10.4.15.1.Overview
      • 10.4.15.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3.Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.15.4.Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.15.5.Rest of APAC Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
  • 10.5.Latin America
    • 10.5.1.Overview
    • 10.5.2.Mesenchymal Stem Cells Key Manufacturers in Latin America
    • 10.5.3.Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4.Latin America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.5.5.Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.6.Latin America Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.5.7.Brazil
      • 10.5.7.1.Overview
      • 10.5.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3.Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.7.4.Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.7.5.Brazil Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.5.8.Mexico
      • 10.5.8.1.Overview
      • 10.5.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3.Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.8.4.Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.8.5.Mexico Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.5.9.Argentina
      • 10.5.9.1.Overview
      • 10.5.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3.Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.9.4.Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.9.5.Argentina Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.5.10.Colombia
      • 10.5.10.1.Overview
      • 10.5.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3.Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.10.4.Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.10.5.Colombia Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.5.11.Rest of LATAM
      • 10.5.11.1.Overview
      • 10.5.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3.Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.11.4.Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.11.5.Rest of LATAM Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
  • 10.6.Middle East and Africa
    • 10.6.1.Overview
    • 10.6.2.Mesenchymal Stem Cells Key Manufacturers in Middle East and Africa
    • 10.6.3.Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4.Middle East and Africa Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.6.5.Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.6.Middle East and Africa Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.6.7.Saudi Arabia
      • 10.6.7.1.Overview
      • 10.6.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3.Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.7.4.Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.7.5.Saudi Arabia Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.6.8.United Arab Emirates
      • 10.6.8.1.Overview
      • 10.6.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3.United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.8.4.United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.8.5.United Arab Emirates Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.6.9.Israel
      • 10.6.9.1.Overview
      • 10.6.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3.Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.9.4.Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.9.5.Israel Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.6.10.Turkey
      • 10.6.10.1.Overview
      • 10.6.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3.Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.10.4.Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.10.5.Turkey Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.6.11.Algeria
      • 10.6.11.1.Overview
      • 10.6.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3.Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.11.4.Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.11.5.Algeria Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.6.12.Egypt
      • 10.6.12.1.Overview
      • 10.6.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3.Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.12.4.Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.12.5.Egypt Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.6.13.Rest of MEA
      • 10.6.13.1.Overview
      • 10.6.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3.Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.13.4.Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.13.5.Rest of MEA Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)

11.Key Vendor Analysis- Mesenchymal Stem Cells Industry

  • 11.1.Competitive Dashboard
  • 11.2.Company Profiles
    • 11.2.1.Takeda Pharmaceutical Company Limited
    • 11.2.2.Merck KGaA
    • 11.2.3.Thermo Fisher Scientific, Inc.
    • 11.2.4.Lonza Group Ltd
    • 11.2.5.Stemcell Technologies, Inc.
    • 11.2.6.Cellular Dynamics International, Inc.
    • 11.2.7.Regeneus Ltd
    • 11.2.8.Tissue Genesis, Inc.
    • 11.2.9.Cesca Therapeutics Inc
    • 11.2.10.Ipsen

12.360 Degree Analyst View

13.Appendix

  • 13.1.Research End-Useology
  • 13.2.References
  • 13.3.Abbreviations
  • 13.4.Disclaimer
  • 13.5.Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Mesenchymal Stem Cells Market: Product Type Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Product Type
  • TABLE Global Mesenchymal Stem Cells Market, by Product Type 2019-2032 (USD Million)
  • TABLE Mesenchymal Stem Cells Market: Application Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global Mesenchymal Stem Cells Market, by Application 2019-2032 (USD Million)
  • TABLE Mesenchymal Stem Cells Market: End-UseSnapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by End-Use
  • TABLE Global Mesenchymal Stem Cells Market, by End-Use2019-2032 (USD Million)
  • TABLE Mesenchymal Stem Cells Market: Regional snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Mesenchymal Stem Cells Market, by Region 2019-2032 (USD Million)
  • TABLE North America Mesenchymal Stem Cells Market, by Country, 2019-2032 (USD Million)
  • TABLE North America Mesenchymal Stem Cells Market, by Product Type, 2019-2032 (USD Million)
  • TABLE North America Mesenchymal Stem Cells Market, by Application, 2019-2032 (USD Million)
  • TABLE North America Mesenchymal Stem Cells Market, by End-Use, 2019-2032 (USD Million)
  • TABLE Europe Mesenchymal Stem Cells Market, by Country, 2019-2032 (USD Million)
  • TABLE Europe Mesenchymal Stem Cells Market, by Product Type, 2019-2032 (USD Million)
  • TABLE Europe Mesenchymal Stem Cells Market, by Application, 2019-2032 (USD Million)
  • TABLE Europe Mesenchymal Stem Cells Market, by End-Use, 2019-2032 (USD Million)
  • TABLE Asia Pacific Mesenchymal Stem Cells Market, by Country, 2019-2032 (USD Million)
  • TABLE Asia Pacific Mesenchymal Stem Cells Market, by Product Type, 2019-2032 (USD Million)
  • TABLE Asia Pacific Mesenchymal Stem Cells Market, by Application, 2019-2032 (USD Million)
  • TABLE Asia Pacific Mesenchymal Stem Cells Market, by End-Use, 2019-2032 (USD Million)
  • TABLE Latin America Mesenchymal Stem Cells Market, by Country, 2019-2032 (USD Million)
  • TABLE Latin America Mesenchymal Stem Cells Market, by Product Type, 2019-2032 (USD Million)
  • TABLE Latin America Mesenchymal Stem Cells Market, by Application, 2019-2032 (USD Million)
  • TABLE Latin America Mesenchymal Stem Cells Market, by End-Use, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Mesenchymal Stem Cells Market, by Country, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Mesenchymal Stem Cells Market, by Product Type, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Mesenchymal Stem Cells Market, by Application, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Mesenchymal Stem Cells Market, by End-Use, 2019-2032 (USD Million)